Pages that link to "Q51344612"

The following pages link to Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma (Q51344612):

Displaying 46 items.

• microRNA: Diagnostic Perspective (Q26797259) (← links)
• The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids (Q26825022) (← links)
• Extracellular microRNAs in urologic malignancies: chances and challenges (Q26866043) (← links)
• Oxidative stress in prostate hyperplasia and carcinogenesis (Q28079474) (← links)
• Elevated serum microRNA levels associate with absence of high-grade prostate cancer in a retrospective cohort (Q28546311) (← links)
• Data Normalization Strategies for MicroRNA Quantification (Q30997590) (← links)
• MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer (Q33709646) (← links)
• MicroRNAs as lung cancer biomarkers (Q34031213) (← links)
• Analysis of tissue and serum microRNA expression in patients with upper urinary tract urothelial cancer (Q35023641) (← links)
• Assessment of RT-qPCR normalization strategies for accurate quantification of extracellular microRNAs in murine serum (Q35106915) (← links)
• Identification of a set of endogenous reference genes for miRNA expression studies in Parkinson's disease blood samples (Q35322482) (← links)
• Plasma Levels of microRNA-145 Are Associated with Severity of Coronary Artery Disease (Q35566567) (← links)
• Circulating microRNA 132-3p and 324-3p Profiles in Patients after Acute Aneurysmal Subarachnoid Hemorrhage (Q35870820) (← links)
• Mechanisms and therapeutic potential of microRNAs in hypertension. (Q36173562) (← links)
• Identification of circulating microRNA signatures for upper tract urothelial carcinoma detection (Q36224827) (← links)
• A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours (Q36750726) (← links)
• Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies (Q37158033) (← links)
• Standardizing analysis of circulating microRNA: clinical and biological relevance (Q37712040) (← links)
• Roles of microRNAs during prostatic tumorigenesis and tumor progression (Q38086009) (← links)
• Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies. (Q38216129) (← links)
• miRNA panels as biomarkers for bladder cancer. (Q38239829) (← links)
• Universal screening test based on analysis of circulating organ-enriched microRNAs: a novel approach to diagnostic screening (Q38263664) (← links)
• Epigenetic biomarkers in the blood of patients with urological malignancies (Q38365422) (← links)
• Evaluating the microRNA-target gene regulatory network in renal cell carcinomas, identification for potential biomarkers and critical pathways (Q38459924) (← links)
• Circulating miRNAs as biomarkers for endocrine disorders (Q38503895) (← links)
• Extracellular vesicle microRNAs: biomarker discovery in various diseases based on RT-qPCR. (Q38569438) (← links)
• Dysregulation and diagnostic potential of microRNA in Alzheimer's disease (Q38612032) (← links)
• Regulation of growth of human bladder cancer by miR-192. (Q38922382) (← links)
• The emerging role of non-coding circulating RNA as a biomarker in renal cell carcinoma (Q38959811) (← links)
• Circulating MicroRNAs as Biomarkers of Prostate Cancer: The State of Play (Q39375743) (← links)
• Different normalization strategies might cause inconsistent variation in circulating microRNAs in patients with hepatocellular carcinoma (Q41831196) (← links)
• Identification of aberrant tRNA-halves expression patterns in clear cell renal cell carcinoma (Q42363975) (← links)
• Assessment of microRNAs in patients with unstable angina pectoris (Q44243789) (← links)
• YRNA expression predicts survival in bladder cancer patients. (Q46596141) (← links)
• Identification of valid reference genes for mRNA and microRNA normalisation in prostate cancer cell lines (Q49191820) (← links)
• RNase H2-Dependent Polymerase Chain Reaction and Elimination of Confounders in Sample Collection, Storage, and Analysis Strengthen Evidence That microRNAs in Bovine Milk Are Bioavailable in Humans (Q49604116) (← links)
• Overexpression of long non-coding RNA RP11-396F22.1 correlates poor prognosis of patients with early-stage cervical cancer. (Q52595118) (← links)
• YRNA expression in prostate cancer patients: diagnostic and prognostic implications. (Q52680358) (← links)
• MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker. (Q54192848) (← links)
• Expression profile of microRNAs in expressed prostatic secretion of healthy men and patients with IIIA chronic prostatitis/chronic pelvic pain syndrome. (Q55222396) (← links)
• miR-224/miR-141 ratio as a novel diagnostic biomarker in renal cell carcinoma. (Q55644580) (← links)
• Identification and validation of circulating miRNAs as endogenous controls in obstructive sleep apnea (Q64099711) (← links)
• [Detection of cell-free lncRNA in serum of cancer patients] (Q85779116) (← links)
• Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer? (Q85784261) (← links)
• Technical Aspects Related to the Analysis of Circulating microRNAs (Q86809678) (← links)
• Human Circulating miRNAs Real-time qRT-PCR-based Analysis: An Overview of Endogenous Reference Genes Used for Data Normalization (Q93155184) (← links)